Recorded Chinese product: 氟罗沙星分散片氟罗沙星分散片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 湖南方盛制药股份有限公司Chinese legal name: 湖南方盛制药股份有限公司
主要成分Active Ingredients
- 氟罗沙星Fuluo Shaxing
药物知识说明
氟罗沙星是一种在国家药监局注册认定的药品。该药品含有氟罗沙星-f87d6279等成分。
该药品关联的活性成分包括：氟罗沙星Fuluo Shaxing。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：湖南方盛制药股份有限公司Chinese legal name: 湖南方盛制药股份有限公司。
您可以探索含有相同成分的其他药品：氟罗沙星-f87d6279成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 氟罗沙星分散片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 氟罗沙星Fuluo Shaxing.
Manufacturers recorded for this product: 湖南方盛制药股份有限公司Chinese legal name: 湖南方盛制药股份有限公司.
Explore other medicines containing the same ingredient: 氟罗沙星 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 氟罗沙星分散片Recorded Chinese product: 氟罗沙星分散片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.1g（按氟罗沙星计）Recorded Chinese specification
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 湖南方盛制药股份有限公司Chinese legal name: 湖南方盛制药股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20060224
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20060224
Manufacturer
Chinese legal name: 湖南方盛制药股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20060224
生产企业
湖南方盛制药股份有限公司(国产)
适应症
可用于对本品敏感细菌引起的急性支气管炎，慢性支气管炎急性发作及肺炎等呼吸系统感染：膀胱炎、肾盂肾炎、前列腺炎、附睾炎、淋病奈瑟菌性尿道炎等泌尿生殖系统感染；伤寒沙门菌感染、细菌性痢疾等消化系统感染：皮肤软组织感染、骨感染、腹腔感染及盆腔感染等。
用法用量
本品为分散片，可直接口服/吞服，或将本品适量投入约100ml水中，振摇分散后口服。||成人常用量：一日0.2～0.4g（2～4片），分1～2次服，一般疗程7～14日。
不良反应
1．胃肠道反应较为常见，可表现为腹部不适或疼痛、腹泻、恶心呕吐、食欲不振等。
禁忌
1．对本品或喹诺酮类药物过敏者禁。|||2．孕妇、哺乳期妇女以及18岁以下者禁用。
注意事项
1．肾功能减退者慎用，若使用，应根据减退程度调整剂量。
贮藏
避光、密封室温干燥处保存。
规格
0.1g（按氟罗沙星计）
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.